Cytopia adds and subtracts
Thursday, 10 July, 2008
Cytopia [ASX: CYT] has appointed Anadys Pharmaceuticals founder Dr Devron Averett as the company's new scientific advisor.
Averett has a Ph.D in microbiology and immunology and is an inventor of 17 current and nine pending US patents. He has had previous roles with Glaxo Wellcome and Burroughs Wellcome.
His work contributed to the discovery of a number of oncology and anti-viral drug candidates, including Zeffix, Emtriva and Ziagen.
The Melbourne-headquartered company has closed its New York office, losing business and corporate development VP Dr Shreefal Mehta, and will concentrate its US operations on California.
It has also appointed financial specialist Richard Haiduck as chief business advisor.
Link between oestrogen and heart health found in women
Scientists found that oestrogen helps increase the ANXA1 protein, and when ANXA1 is missing, the...
Frequent nightmares accelerate aging, increase risk of death
Nghtmares independently predict faster biological aging and earlier mortality — even after...
Cardiac organoids bring hope for treating heart disease
Australian scientists have developed lab-grown, three-dimensional heart tissues known as cardiac...
